STAT3 and Alzheimer disease: Thus, STAT1 GOF mutations have become diagnostic for AD-CMC [106], LOF mutations in STAT3 (and other components of the IL-6 signaling pathway) for HIES [64], and LOF mutations in STAT1 (and other components of the IFNγ signaling pathway) for MSMD [46].